Literature DB >> 4159313

Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss.

J K Spitznagel.   

Abstract

Spitznagel, John K. (University of North Carolina School of Medicine, Chapel Hill). Normal serum cytotoxicity for P(32)-labeled smooth Enterobacteriaceae. III. Isolation of a gammaG normal antibody and characterization of other serum factors causing P(32) loss. J. Bacteriol. 91:401-408. 1966.-Gram-negative bacteria lost metabolically incorporated P(32) when suspended in serum only if the serum contained heat-labile in addition to heat-stable factors. Gram-positive bacteria labeled with P(32) and included for comparison lost P(32) in heat-inactivated as well as in fresh normal serum. Further investigation of gram-negative bacteria showed that a smooth Escherichia coli (O117:H27) lost P(32) only if suspended in serum containing complement fractions C'1, C'2, C'3, and C'4 "normal" antibody and lysozyme. The normal antibody was recovered by absorption on and subsequent elution from E. coli O117:H27 cell walls. Immunoelectrophoresis showed that it was a gammaG-globulin. Its P(32)-releasing activity was destroyed by 2-mercaptoethanol. Lysozyme was found to potentiate the P(32)-releasing action of normal antibody plus complement. Evidence was obtained suggesting that beta(1C) globulin was the component absorbed to zymosan during serum absorption at 15 C. Reduction of the beta(1C) level evidently upsets an important balance that exists in normal serum among complement, antibody, and lysozyme. This balance is essential for maximal P(32) release from labeled bacteria, or possibly for a maximal antibacterial effect from normal serum. The possible relationships of bactericidal, bacteriolytic, and opsonic action of normal serum are discussed.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4159313      PMCID: PMC315960          DOI: 10.1128/jb.91.1.401-408.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  PROPERTIES OF GUINEA PIG 7S ANTIBODIES. IV. ANTIBODY RESPONSE TO E. COLI BACTERIA.

Authors:  K J BLOCH; F M KOURILSKY; Z OVARY; B BENACERRAF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  INFLUENCE OF 2-MERCAPTOETHANOL TREATMENT ON OPSONIZING ACTIVITY OF HUMAN AND RABBIT 7S ANTIBODIES.

Authors:  H NAGASHIMA; G WIEDERMANN; G HERMANN; P A MIESCHER
Journal:  Vox Sang       Date:  1965 May-Jun       Impact factor: 2.144

4.  Effect of mercaptoethanol on complement binding ability of human 7 S gammaglobulin.

Authors:  G WIEDERMANN; P A MIESCHER; E C FRANKLIN
Journal:  Proc Soc Exp Biol Med       Date:  1963-07

5.  The role of opsonins in the clearance of living and inert particles by cells of the reticuloendothelial system.

Authors:  C R JENKIN; D ROWLEY
Journal:  J Exp Med       Date:  1961-09-01       Impact factor: 14.307

6.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

7.  The bactericidal action of normal serum and the properdin system.

Authors:  E OSAWA; L H MUSCHEL
Journal:  J Immunol       Date:  1960-02       Impact factor: 5.422

8.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

9.  Isolation and characterization of two beta1-glycoproteins of human serum.

Authors:  H J MULLER-EBERHARD; U NILSSON; T ARONSSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

10.  The fate of bacteria within phagocytic cells. I. The degradation of isotopically labeled bacteria by polymorphonuclear leucocytes and macrophages.

Authors:  Z A COHN
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

View more
  9 in total

1.  Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum.

Authors:  A Fietta; E Romero; A G Siccardi
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

2.  Interaction of complement and polymyxin with gram-negative bacteria.

Authors:  H Pruul; B L Reynolds
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

Review 3.  Antibody heterogeneity and serological reactions.

Authors:  R M Pike
Journal:  Bacteriol Rev       Date:  1967-06

4.  Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.

Authors:  L A Wilson; J K Spitznagel
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

5.  The adherence to Salmonella enteritidis of IgG, IgM and B1C-Globulins from guinea-pig serum.

Authors:  K D Beernink; J P Steward
Journal:  Immunology       Date:  1968-08       Impact factor: 7.397

6.  Increased antibacterial activity against Escherichia coli in bovine serum after the induction of endotoxin tolerance.

Authors:  A W Hill; A L Shears; K G Hibbitt
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage.

Authors:  J K Spitznagel; L A Wilson
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

8.  Antibiotic, detergent, and complement sensitivity of Salmonella typhi after ethylenediaminetetraacetic acid treatment.

Authors:  L H Muschel; L Gustafson
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

9.  Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.

Authors:  R D Schreiber; D C Morrison; E R Podack; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.